Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single arm cohort study to see efficacy and safety of tenofovir
disoproxil fumarate (TDF) in naïve chronic hepatitis B, retrospectively and prospectively
both.
Details
Lead Sponsor:
Myeong Jun Song
Collaborators:
Chungnam National University Hospital Gilead Sciences Konyang University Hospital Soonchunhyang University Hospital Wonkwang University